# Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND)

> **NCT05522569** · — · NO_LONGER_AVAILABLE · sponsor: **University of Miami**

## Conditions studied

- Acute Ischemic Stroke
- Mesenchymal Stem Cells
- Stroke, Acute
- Stroke/Brain Attack
- Stroke, Ischemic

## Interventions

- **DRUG:** Allogeneic human mesenchymal stem cells (Allo-hMSCs)

## Key facts

- **NCT ID:** NCT05522569
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05522569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05522569, "Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND)". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT05522569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*